Cas no 14481-60-8 (Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2))
Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) Chemical and Physical Properties
Names and Identifiers
-
- Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2)
- disodium,4-(octadecylamino)-4-oxo-2-sulfonatobutanoate
- DisodiumN-octadecylsulfosuccinamate
- N-OCTADECYL DISODIUM SULFOSUCCINATE
- Butanedioic acid,sulfo-,monooctadecyl ester,disodium salt
- Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-,disodium salt
- Disodium N-stearyl-2-sulfosuccinamate
- Disodium stearyl sulfosuccinamate
- EINECS 238-479-5
- Butanoicacid, 4-(octadecylamino)-4-oxo-2-sulfo-, disodium salt (9CI)
- Succinamic acid,N-octadecyl-2-sulfo-, disodium salt (7CI,8CI)
- Succinamic acid,N-octadecylsulfo-, disodium salt (6CI)
- A 18
- A 18 (surfactant)
- Aerosol 18
- Alcopol FA
- Alkasurf SS-TA
- Astromid 18
- Lipal NTD
- Octosol A18
- Stanfax 318
- N-octadecyl sulfosuccinamate disodium salt
- N-Octadecylsulfosuccinamic acid sodium salt
- Dinatrium-4-(octadecylamino)-4-oxo-2-sulfonatobutyrat
- disodium 4-(octadecylamino)-4-oxo-2-sulphonatobutyrate
- 4-(octadecylamino)-4-oxo-2-sulfo-butanoicacidisodiumsalt
- Lankropol ODS
-
- Inchi: 1S/C22H42O7S.2Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-29-22(25)20(19-21(23)24)30(26,27)28;;/h20H,2-19H2,1H3,(H,23,24)(H,26,27,28);;/q;2*+1/p-2
- InChI Key: IRWMJXDNLGBJKQ-UHFFFAOYSA-L
- SMILES: C(S([O-])(=O)=O)(CC([O-])=O)C(=O)OCCCCCCCCCCCCCCCCCC.[Na+].[Na+]
Computed Properties
- Exact Mass: 494.22900
Experimental Properties
- PSA: 132.01000
- LogP: 4.92570
Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| A2B Chem LLC | AF00390-25g |
N-OCTADECYL DISODIUM SULFOSUCCINATE |
14481-60-8 | ≥33% | 25g |
$28.00 | 2024-04-20 | |
| A2B Chem LLC | AF00390-100g |
N-OCTADECYL DISODIUM SULFOSUCCINATE |
14481-60-8 | ≥33% | 100g |
$60.00 | 2024-04-20 | |
| A2B Chem LLC | AF00390-500g |
N-OCTADECYL DISODIUM SULFOSUCCINATE |
14481-60-8 | ≥33% | 500g |
$104.00 | 2024-04-20 |
Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) Suppliers
Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) Related Literature
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
Additional information on Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2)
Research Brief on Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) (CAS: 14481-60-8)
Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2) (CAS: 14481-60-8) is a specialized surfactant and amphiphilic compound with potential applications in pharmaceutical formulations, drug delivery systems, and biochemical research. Recent studies have explored its physicochemical properties, biological interactions, and industrial utility, highlighting its unique structural features and functional versatility.
A 2023 study published in the Journal of Colloid and Interface Science investigated the self-assembly behavior of this compound in aqueous solutions. The research demonstrated that its sulfonate and amide groups facilitate micelle formation at low critical micelle concentrations (CMCs), making it a promising candidate for stabilizing hydrophobic drug molecules. Molecular dynamics simulations further revealed its ability to form stable complexes with lipid bilayers, suggesting potential applications in targeted drug delivery.
In the context of antimicrobial research, a team from the University of Tokyo (2024) reported that derivatives of this compound exhibit moderate activity against Gram-positive bacteria, likely due to their membrane-disrupting properties. The sodium salt's amphiphilic nature enables it to integrate into bacterial cell membranes, though cytotoxicity profiles indicate the need for further structural optimization for therapeutic use.
Industrial applications were highlighted in a recent patent (WO2023124567) describing its use as a stabilizer in nanoparticle synthesis. The compound's dual hydrophilic-lipophilic balance (HLB ~14) allows for precise control of silver and gold nanoparticle morphology, with implications for diagnostic and therapeutic nanotechnologies.
Ongoing clinical research (Phase I trials) is evaluating its role as an excipient in novel mRNA vaccine formulations, where preliminary data suggest enhanced thermal stability of lipid nanoparticles. However, regulatory challenges remain regarding the compound's metabolic fate, as in vivo studies show partial accumulation in hepatic tissues.
Future research directions include computational modeling of structure-activity relationships and exploration of chiral variants for enhanced biological specificity. The compound's unique CAS registry (14481-60-8) continues to serve as a key identifier in global chemical databases, facilitating interdisciplinary research across material science and pharmaceutical chemistry domains.
14481-60-8 (Butanoic acid,4-(octadecylamino)-4-oxo-2-sulfo-, sodium salt (1:2)) Related Products
- 2673-22-5(Sodium 1,4-dioxo-1,4-bis(tridecyloxy)-butane-2-sulfonate)
- 19040-44-9(Butanedioic acid,2-sulfo-, 1-dodecyl ester, sodium salt (1:2))
- 1639-66-3(Dioctylsulfosuccinic Acid Sodium Salt)
- 3246-20-6(Butanedioic acid,2-sulfo-, 1,4-dinonyl ester, sodium salt (1:1))
- 10027-28-8(Butanedioic acid,2-sulfo-, 1,4-dioctadecyl ester, sodium salt (1:1))
- 10044-00-5(Butanedioic acid,2-sulfo-, 1,4-dihexadecyl ester, sodium salt (1:1))
- 26838-05-1(Steinapol SBF 12)
- 3006-15-3(Butanedioic acid,2-sulfo-, 1,4-dihexyl ester, sodium salt (1:1))
- 103900-46-5(Butanedioic acid,2-sulfo-, 1-dodecyl 4-ethyl ester, sodium salt (1:1))
- 23524-64-3(Butanedioic acid,2-sulfo-, 1,4-didecyl ester, sodium salt (1:1))